10.1016/j.exger.2007.05.004 91 LiX.ChauhanA.SheikhA
Shotsy generates a polished PDF containing dose history, weight trends with visual charts, injection sites, and side effects, formatted specifically for clinical review
Treatment with 1 M Fer-1, a ferroptosis inhibitor, for 2 weeks, resulted in a reduction of extracellular A deposition (Fig
However, the underlying mechanisms of these cardioprotective effects, including improvement of mitochondrial functions, following GLP-1R stimulation have not completely clarified
doi: 10.3390/ijms23020739
Intervention: Any GLP-1 receptor agonist, including liraglutide, semaglutide, dulaglutide, exenatide, or lixisenatide